Looking for an EU project partner in computational drug discovery, AI or HPC?
BIO-HPC at UCAM is a research group with 25 years of HPC-driven drug discovery, a pipeline of 12 active programs, 8 patents and 2 clinical studies — available to join Horizon Europe, EIC and MSCA consortia as a research partner.
What we bring to a consortium
A combination of methods, infrastructure and translational track record that few academic groups in Spain can match.
Computational drug discovery
End-to-end virtual screening, molecular docking, molecular dynamics, pharmacophore modelling and consensus methods applied to academic, biotech and pharma targets.
- 12 in-house software tools (open-source)
- Structure-based and ligand-based pipelines
- ML-augmented enrichment (ESSENCE-Dock)
HPC capacity & AI on HPC
Direct access to UCAM’s HPC infrastructure and active allocations on national/European supercomputing networks (BSC, NLHPC, PSNC, HPC-Europa).
- Interpretable ML / XAI models (SIBILA)
- ADMET, QSAR and target-activity prediction
- Containerised reproducible pipelines
Translation & IP
8 granted patents (incl. antiviral and anti-obesity), licensing track record and 2 ongoing clinical studies in Murcia. Commercial routes through UCAM’s Technology Transfer Office (OTRI).
- Fascin inhibitor — colorectal cancer (clinical, 2022)
- Pancreatic lipase — obesity (clinical, 2023)
- Spin-off Inmolnova being established
Where we fit in Horizon Europe
Our methods and HPC infrastructure plug directly into multiple Horizon Europe clusters and EIC programmes.
Pillar 2 · Cluster 1
Health
Drug discovery against oncology, metabolic, infectious and neurological targets. Repurposing, AI-driven hit-to-lead, and translation to clinical studies.
Pillar 2 · Cluster 4
Digital, Industry & Space
AI on HPC, interpretable ML for biological and industrial data, GPU-accelerated computational chemistry.
Pillar 1
European Research Council
Available as Spanish host institution for ERC Starting, Consolidator or Advanced Grant applicants whose programme aligns with our HPC-driven drug discovery agenda.
EIC
Pathfinder, Transition, Accelerator
Methods-led partner for early-stage Pathfinder and validation/scale-up partner for Transition and Accelerator projects in the drug-discovery space.
Pillar 1
MSCA
Host institution for Postdoctoral Fellowships, Staff Exchanges and Doctoral Networks. See our MSCA hosting page.
Calls open to academia & SMEs
Industry-led consortia
We routinely partner with biotech and pharma SMEs as the computational/HPC arm of consortia. Through UCAM-OTRI we sign standard EC consortium agreements.
Selected EU-funded projects we’ve been part of
Concrete track record across Horizon 2020, FP7, PRACE and Spanish national calls — with UCAM either coordinating or as a research partner.
- REVERT — Horizon 2020, grant agreement 848098. EU consortium of 14 institutions on AI-driven personalised medicine for metastatic colorectal cancer. UCAM was the computational/AI partner.
- Eurolab-4-HPC — Horizon H2020-FETHPC-2014, grant agreement 671610. Business prototyping in HPC and computational chemistry, with UCAM as a project leader on the prototyping work.
- TETRACOM — FP7 Technology Transfer in Computing Systems, transfer of computational-chemistry methods to industry (UCAM as leader).
- PRACE DECI-10 — Distributed European Computing Initiative call on novel anticoagulants discovered with computational chemistry.
- Nils Science and Sustainability — Iceland-Liechtenstein-Norway / Spain bilateral programme on hybrid AI for blood-anticoagulant discovery.
- HPC-Europa3 — recurring transnational access calls for in-house and visiting researchers on European supercomputers.
Who we’ve sat at the same consortium table with
A representative list from the REVERT H2020 consortium and other joint projects — the kind of partners we’ve actually co-written work-packages and co-managed deliverables with.
EU academic & clinical centres
San Raffaele Roma · Università degli Studi di Roma Tor Vergata · Università di Firenze · Azienda ULSS 4 Veneto Orientale (ProMIS) · Local Health Unit 3 “Serenissima” · “Paolo Giaccone” University Hospital of Palermo · ISPRO · Malmö University · Umeå University · Lund University Hospital · Luxembourg Institute of Health (LIH) · Institutul Regional de Oncologie Iași (IRO Iassy) · Spitalul Spiridon Iași · IMAGO-MOL · University of Łódź · Bundesanstalt für Materialforschung und Prüfung (BAM) · Universidad Autónoma de Madrid · Universidad de Granada · Universitat de València · UPCT · Universidad de Almería · UPV.
European SME & industrial partners
GenXPro GmbH · BIOVARIANCE GmbH · Olomedia · Romsoft · SC EUROCLINIC · UTGAD Iași · Eurofins Villapharma · Hijos de Rivera · GOURA Investigaciones · Columba Investigaciones · FX Talentum · Aquaporins and Ingredients · ProtoQSAR · plus SME partners in agri-food and cosmetics on national contracts.
Public health & e-Infrastructure
Servicio Murciano de Salud (SMS) · Foundation for Health Training and Research of Murcia Region (FFIS) · Barcelona Supercomputing Center (BSC) · HPC-Europa3 · PRACE · PSNC (Poznań, Poland) · NLHPC (Chile) · national Spanish supercomputing infrastructure (RES).
How to engage
From the first email to a signed consortium agreement, our route is short and direct.
- 1. Email Prof. Horacio Pérez-Sánchez with your project idea and the call you are targeting (Horizon Europe, EIC, ERC, MSCA, national).
- 2. We respond within 1–3 working days with a fit-assessment, suggested role in the consortium and a short capability statement for your proposal annex.
- 3. We co-write the technical work-packages related to computational drug discovery, AI/ML or HPC. We can also support outreach, dissemination and ethics work-packages.
- 4. UCAM’s Technology Transfer Office (OTRI) handles the legal and financial side: PIC, LEAR, accession forms, consortium agreement, IP clauses, etc.
- 5. Once awarded, our team integrates immediately. The group operates as a small, agile research group with direct access from PI to junior researcher — no bureaucratic friction.
Have an open call or a draft proposal? Let’s talk.
We respond to all enquiries within a few working days. For time-sensitive calls (e.g. EIC cut-offs, MSCA deadlines), please mention the deadline in the subject line.
Prof. Horacio Pérez-Sánchez, PhD · Director, BIO-HPC Research Group · UCAM Universidad Católica de Murcia
hperez@ucam.edu